Covered recipient · General Payments record
JOSEPH SCAMARDO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2023
$3,381.84
- Reported across 241 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $536.16 | 34 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $204.33 | 14 |
| Corium, Inc. | $86.72 | 6 |
| PFIZER INC. | $84.88 | 5 |
| Teva Pharmaceuticals USA, Inc. | $68.06 | 4 |
| SK Life Science, Inc. | $34.15 | 2 |
| Lilly USA, LLC | $24.62 | 1 |
| Supernus Pharmaceuticals, Inc. | $17.82 | 1 |
| Otsuka America Pharmaceutical, Inc. | $15.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $12.48 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843581 | CMS |
| AbbVie Inc. | $17.38 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843585 | CMS |
| AbbVie Inc. | $21.23 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843589 | CMS |
| AbbVie Inc. | $23.85 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843593 | CMS |
| AbbVie Inc. | $6.88 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843595 | CMS |
| AbbVie Inc. | $27.91 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843600 | CMS |
| AbbVie Inc. | $13.62 | 08/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843604 | CMS |
| AbbVie Inc. | $5.95 | 08/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843609 | CMS |
| AbbVie Inc. | $6.11 | 08/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843613 | CMS |
| AbbVie Inc. | $16.39 | 09/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843617 | CMS |
| AbbVie Inc. | $20.89 | 10/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843619 | CMS |
| AbbVie Inc. | $6.30 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843624 | CMS |
| AbbVie Inc. | $3.06 | 10/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843629 | CMS |
| AbbVie Inc. | $22.28 | 11/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998843633 | CMS |
| Corium, LLC | $17.81 | 02/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978032511 | CMS |
| Corium, LLC | $16.37 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978514893 | CMS |
| Corium, LLC | $15.01 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978353667 | CMS |
| Corium, LLC | $12.51 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978353675 | CMS |
| Corium, LLC | $12.51 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978579175 | CMS |
| Corium, LLC | $12.51 | 11/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026467147 | CMS |
| Lilly USA, LLC | $24.62 | 11/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031601903 | CMS |
| Otsuka America Pharmaceutical, Inc. | $15.58 | 07/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014787379 | CMS |
| PFIZER INC. | $18.06 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049610991 | CMS |
| PFIZER INC. | $19.69 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049407997 | CMS |
| PFIZER INC. | $15.77 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049176031 | CMS |
| PFIZER INC. | $14.08 | 08/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049966087 | CMS |
| PFIZER INC. | $17.28 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050181807 | CMS |
| SK Life Science, Inc. | $16.99 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054812269 | CMS |
| SK Life Science, Inc. | $17.16 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054812359 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.82 | 08/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053306285 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.80 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056854795 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.73 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056854853 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.73 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056854873 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.80 | 10/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056854929 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.